Hello, Fool! | Login | Signup | My Fool
Oct 11, 2008 3:09 AM ET | Feedback | Site Changes | Help
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
View Ticker Page (BMRN)
Results 11 - 20 of 103 : 12345Next »
Recs
mrtardy (< 20) Submitted: 1/28/07 12:46 AM : Start Price: $18.20 BMRN Score: 47.15
This company develops drugs in a sub-market where there is little or no competition. Their management is top notch and they are invested in the company. The stock today is at 39.76% above my purchase price in January of 2006. I'm no broker, but un...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Sandman333 (< 20) Submitted: 11/09/07 11:24 AM : Start Price: $16.82 BMRN Score: 55.59
I've had real money in this stock in my Roth IRA 1-11-2005. So far, I am up 333%. With a significant moat to protect their bottom line, what's not to like? Just wish I had sunk more money into them- might have been able to retire earlier.
gklein711 (36.84) Submitted: 1/01/08 8:57 AM : Start Price: $35.49 BMRN Score: -4.30
Company continues to have momentum, has highly promising drug.
zzlangerhans (98.66) Submitted: 6/11/08 10:37 PM : Start Price: $36.11 BMRN Score: -10.48
The recent pullback in share price makes Biomarin attractive since they haven't had any negative developments. Biomarin is definitely a solid company marketing very effective treatments, but now that they are profitable their share price is more vuln...
JJDsurfer (< 20) Submitted: 10/11/06 8:04 PM : Start Price: $16.48 BMRN Score: 55.52
Bio pharmacetucal firm that focuses on rare diseases.
ethicalfool (< 20) Submitted: 8/31/06 9:28 PM : Start Price: $16.57 BMRN Score: 52.67
Almost a 3X already for me, more room to run.
Report this Post Replies: 1 | Reply | Permalink
skullchemist (< 20) Submitted: 8/29/06 7:58 AM : Start Price: $15.39 BMRN Score: 61.32
solid leadership, good pipeline of orphan drugs, a monster guide up in the last earnings call. . . . you good hear it in their voices. . this company is going places
bill75 (< 20) Submitted: 8/26/06 10:32 PM : Start Price: $15.75 BMRN Score: 58.16
Ready to move again.
Power78 (30.71) Submitted: 9/08/06 5:49 AM : Start Price: $15.55 BMRN Score: 60.00
Barring any unforseen setbacks in the clinical trials of some of its new drugs I see BioMarin getting into the black in the next couple of years and growing steadily
bigbubba49 (< 20) Submitted: 8/18/08 10:30 PM : Start Price: $25.76 BMRN Score: 7.84
Biomarin targets diseases caused by genetic defects. Most of these are relatively rare, so there is not a large market, and this makes it less likely that a lot of competitors will get into the business. Also, the nature of the drug creation and te...